FRANCESCO DELLA VALLE,GABRIELE MARCOLONGO,MARIA FEDERICA DELLA VALLE,SALVATORE CUZZOCREA
申请号：
PT14173129
公开号：
PT2821083T
申请日:
2014.06.19
申请国别(地区):
PT
年份:
2016
代理人:
摘要：
The present invention relates to a therapy of renal diseases characterized by alterations of the kidney function, such as Chronic Kidney Disease (CKD), acute and chronic renal impairment, particularly, but not limited to, renal diseases that develop in diabetic patients or in patient who underwent an anticancer chemotherapic treatment with a platinum derivative, and more generally, cytotoxic drugs at the kidney level for treating neoplastic diseases. Particularly, the present invention relates to a combination of compounds selected from mono- or diamide of a C12-C20 monocarboxylic acid, saturated or monounsaturated, or of a C4-C14 dicarboxylic acid, saturated or monounsaturated, with an aminoalkanol, and of compounds selected from Silymarin, derivatives thereof or conjugates or complexes thereof, for use in the treatment of renal diseases, wherein said mono- or diamide of a C12-C20 monocarboxylic acid, saturated or monounsaturated, or of a C4-C14 dicarboxylic acid, saturated or monounsaturated, with an aminoalkanol and said Silymarin, derivatives thereof or conjugates or complexes thereof are formulated for a separate, sequential, concomitant administration or in admixture, also in a co-micronized or co-ultra-micronized form.
